0 results for 'Susman Godfrey'
Susman Godfrey Focused on Innovation, Efficiency Before They Were 'Buzzwords'
The firm has been competing with larger counterparts in Big Law for over four decades, using its size to its advantage.
Which Lone Star Law Firm Will Make the First Associate Salary Move?
Texas firms taking time to consider whether to meet new, higher market rates for associate salaries.
Daily Dicta: Egg on Their Faces: Plaintiffs Giants Come up Empty in $3B Antitrust Trial
Ten co-defendants settled for a combined $150 million, but the trio of egg producers left standing were willing to risk everything by going to trial. Their gamble paid off.
3 NY Boutiques Among Those Matching Milbank on Associate Pay
Several elite litigation boutiques are keeping pace with salary increases at Milbank and Cravath. One hints it's about to go even higher.
Midsize Boutiques Acted Quickly to Keep Up on Associate Comp
At most midsize law firms, matching Milbank is not in the cards. But for highly profitable boutiques, it was the obvious choice.
Elite Boutiques Quick to Match Milbank on Associate Pay
Several litigation boutiques, including Hueston Hennigan and Irell & Manella in Southern California, are keeping pace with salary increases at Milbank and Cravath.
These Boutiques Aren't Hesitating to Match Milbank on Associate Pay
Several elite litigation boutiques are keeping pace with salary increases at Milbank and Cravath. One hints it's about to go even higher.
NY Law Journal Announces Attorney of the Year Finalists
We don't announce the winner for Attorney of the Year until our recognition dinner in October but we are pleased to recognize our three finalists today.
New York Law Journal Names Its Rising Stars
Our Rising Stars award recognizes the region's most promising lawyers who are no older than 40 by the date of submission.
Del. Justices Uphold $70M in Damages for Failing to Market Chemo Drug
The Delaware Supreme Court on Monday upheld a $71 million award against a Pennsylvania-based pharmaceutical company that failed to live up to its obligation to market a drug used to treat exposure to certain types of chemotherapy.